| Year of establishment |
1994 |
1989 |
1983 |
| Location |
Brong Ahafo Region, middle belt of Ghana |
Kilifi County, Kenyan Coast |
Ouagadougou |
| Institutional size (research capacity) year 2012/13 |
Over 600 staff (120 researchers) |
Over 800 staff (77 researchers) |
Over 150 staff (57 researchers) |
| Year clinical trial facility established |
2005 |
2007 |
2009 |
| Examples of malaria clinical trials conducted |
RTS,S phase II and phase III malaria vaccine trials, Artemether-Lumefantrine malaria drug trial |
RTS,S phase II and phase III malaria vaccine trials, TrapVac trial, ME-Trap vaccine trial, Artemether-Lumefantrine malaria drug trial |
Phase IIb GMZ 2 malaria vaccine trial, Phase IIb ME-TRAP candidate malaria vaccine trial, Phase Ib MSP 3 candidate vaccine, Artemether-Lumefantrine malaria drug trial |
| Malaria transmission |
High endemic region |
Low endemic region |
Hyper-endemic with seasonal malaria transmission |
| Poverty levels |
25% of its population in the lowest wealth quintile |
Over 60% of the population living below poverty lines |
Estimated to be at 40% |
| Literacy levels |
Over 52% with no formal education |
About 45% of adults unable to read and write |
Estimated to be at 21.8% |
| Main economic activities |
Subsistence farming |
Subsistence farming, small scale fishing and mining |
Subsistence farming, craft industries, fishing and local manufacturing |
| Predominant group(s) |
Akans (bonos) and Mos, Wangaras, Gonja and Mamprusi (Northern region) |
Mijikenda |
Goin, Karaboro and the Turka |
